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Background: Subcortical hypodensities of presumed vascular etiology (SHPVO) are a clinical, radiological and
neuropathological syndrome with a still largely unexplained pathophysiology. Parallel to the clinical heterogeneity,
there is also recognised cerebral topographical diversity with undetermined etiological implications. Our aim is to
assess clinical and neurosonological predictors of SHPVO according to their location.
Methods: Cross sectional analysis of consecutive patients that underwent neurosonologic evaluation and head CT
within one month, during a one year period. We excluded patients with absent temporal sonographic window, any
pathology with a possible confounding effect on cerebral arterial pulsatility, atrial fibrillation and other etiologies of
white matter diseases. The mean pulsatility index (PI) of both middle cerebral arteries was measured in the middle
third of the M1 segment; intima media thickness was evaluated in the far wall of both common carotid arteries.
SHPVO were rated by analysis of head CT in deep white matter (DWMH), periventricular white matter (PVWMH)
and basal ganglia (BGH). We conducted a multivariate ordinal logistic regression model including all clinical,
demographic and ultrasonographic characteristics to determine independent associations with SHPVO.
Results: We included 439 patients, mean age 63.47 (SD: 14.94) years, 294 (67.0%) male. The independent predictors
of SHPVO were age (OR = 1.067, 95% CI: 1.047-1.088, p < 0.001 for DWMH; OR = 1.068, 95% CI: 1.049-1.088, p < 0.001
for PVWMH; OR = 1.05, 95% CI: 1.03-1.071, p < 0.001 for BGH), hypertension (OR = 1.909, 95% CI: 1.222-2.981, p = 0.004
for DWMH; OR = 1.907, 95% CI: 1.238-2.938, p = 0.003 for PVWMH; OR = 1.775, 95% CI: 1.109-2.843, p = 0.017 for BGH)
and PI (OR = 17.994, 95% CI: 6.875-47.1, p < 0.001 for DWMH; OR = 5.739, 95%CI: 2.288-14.397, p < 0.001 for PVWMH;
OR = 11.844, 95% CI: 4.486-31.268, p < 0.001 for BGH) for all locations of SHPVO.
Conclusions: Age, hypertension and intracranial pulsatility are the main independent predictors of SHPVO across
different topographic involvement and irrespective of extracranial atherosclerotic involvement.
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Subcortical hypodensities of presumed vascular etiology
(SHPVO) are radiological findings defined as rounded
ill-defined areas of decreased attenuation on CT with
increased signal on T2-weighted MR sequences such as
fluid-attenuated inversion recovery [1,2]. Their wide
clinical spectrum includes memory impairment, execu-
tive dysfunction, mood disorders and gait impairment
[3-6]. Recognised as a feature of small vessel disease (SVD)
this clinical, cognitive, radiological and neuropathological
syndrome remains with a largely unexplained patho-
physiology, despite numerous scientific attempts to
address the mechanisms underlying its development
and progression [1,7,8]. Parallel to the clinical hetero-
geneity, there is also topographical diversity in these
subcortical hypodensities, with involvement of deep
white matter, periventricular white matter, subcortical
grey matter and brainstem. Recently, an international ef-
fort was built trying to homogenize concepts, terminology
and future research goals, and one of the main knowledge
gaps identified was the possible differential mechanisms
implied in the origin of these subcortical changes accor-
ding to their location in the brain [8].
Complementing classical neuroimaging studies, neu-
rosonological techniques offer distinctive information,
namely through the possibility of evaluating cerebro-
vascular hemodynamics [9], conveying in vivo evalu-
ation of the proceedings of brain response to vascular
injury. Furthermore, the development of new pharma-
cological strategies and the clarification of new pro-
posed mechanisms of action for older medications that
have been suggested to promote a cerebral vasoactive
effect, highlight potential treatment implications in eluci-
dating the pathological impact of cerebral hemodynamics
in SVD [10-14].
The primary objective of our work is to use a combined
clinical, neuroimaging and neurosonologic approach to
clarify possible differential mechanisms responsible for




We included all consecutive patients undergoing ultrasono-
graphic evaluation in our institution’s neurosonology
laboratory during the year 2011.
We excluded patients without neuroimaging exam
performed within one month of neurosonologic evalu-
ation, absent temporal sonographic window and patients
with any pathology capable of a confounding effect on
cerebral arterial pulsatility. Namely, we excluded all pa-
tients with stenosis >50% in any supra-aortic cervical ar-
tery [15], ≥80% stenosis in any intracranial artery [16], any
grade of stenosis in a Middle Cerebral Artery (MCA) [16],occlusion in an extra or intracranial artery [15,17], all eva-
luations performed in context of subarachnoid haemor-
rhage, acute ischemic stroke, intracranial hypertension,
brain death or arteriovenous malformations (Figure 1).
We also excluded patients with atrial fibrillation (per-
sistent, permanent or paroxysmal forms were consi-
dered) and specific diagnosis of cerebral white matter
diseases such as Multiple Sclerosis and other inflamma-
tory diseases. In cases of duplicate evaluations only the
first study was considered. Signed informed consent was
obtained for all patients. The study was approved by the
local ethics committee of the Coimbra University and
Hospital Centre.
Ultrasound examination
The hemodynamic evaluation was performed through a
predetermined acquisition protocol by two neurosonolo-
gists of equal experience and background using a
General Electric® ultrasonography system, model Logiq
7. A linear probe of 7.5 MHz was used for the extracra-
nial evaluation and a 3.0 MHz sector probe for the
transcranial examination.
The carotid images were obtained with the patient in the
supine position with the neck mildly extended and the
head rotated contralaterally to the side examinated. Intima
media thickness (IMT) was measured in the far wall of the
distal Common Carotid Artery, 10 mm proximal to the ca-
rotid dilation, using optimal insonation angles [18,19]. The
evaluation was performed in both Common Carotid
Arteries and a mean value was calculated. The intracranial
assessment was performed with the patient lying still in
the supine position, after at least 10 minutes of rest,
through an optimal transtemporal window in the middle
third of the M1 segment of both MCAs. Pulsatility indexes
were measured according to the Gosling formula (diffe-
rence between peak systolic and lowest diastolic flow ve-
locities, referenced to time-averaged flow velocity) [20-23].
For the analysis, the mean of pulsatility indexes (PI) from
both arteries were used.
Neuroimaging examination
All patients underwent a head CT, performed with the
same scanner, a 64-slice multidectector CT (GE Light-
speed). Acquisitions were performed without contrast,
from the base of the skull to the vertex. CT technical pa-
rameters included the following: matrix, 512 × 512; SFOV
25 cm; CTDlvol 76.07 mGy; 330 mAs; 120 kV; section
thickness, 5 mm supratentorial, 2.5 mm infratentorial. A
brain parenchymal algorithm was used to analyse the im-
ages on a computer screen. SHVPO were rated by two
neuroradiologists on computer screen, blinded to clinical
and ultrasound data. Ratings were done analysing CT im-
ages acquired within one month of the neurosonologic
study. We graded SHPVO separately according to their
1015 patients screened
Absent transtemporal window: 346 (34.1%)
Sub-arachnoid hemorrhage/ acute stroke/ 
AF/ other white matter diseases: 253 
(25.0%)
Neuroimaging not available: 89 (8.8%)
Intracranial or extracranial 




Figure 1 Number of patients screened, included and excluded from the study.
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periventricular white matter hypodensities (PVWMH) and
basal ganglia hypodensities (BGH). Infratentorial lesions
were not evaluated. DWMH were scored according to the
age related white matter changes scale (ARWMC) as 0 (no
lesions), 1 (focal hypodense areas of ≥5 mm), 2 (beginning
confluence) and 3 (diffuse involvement of the entire re-
gion, with or without involvement of U fibers) [2]. BGH
were also scored using ARWMC as 0 (no lesions), 1 (one
focal lesion ≥5 mm), 2 (>1 lesion) and 3 (confluent lesions)
[2]. For PVWMH grading we used the operacionalized
ARWMC scale definitions with a score of 0 for symmet-
rical, well-defined periventricular hypodensities, 1 (non-
symmetrical caps or bands <5 mm), 2 (periventricular
hypodensities between 5 and 10 mm) and 3 (periventricu-
lar hypodensities >10 mm) [24]. In patients with territorial
infarctions, these lesions were not accounted as a SHPVO.
Clinical information
Classical vascular risk factors, namely arterial hyperten-
sion, diabetes mellitus (DM), dyslipidemia, heart failure,
prior coronariopathy (both myocardial infarction and
angina pectoris were considered), atrial fibrillation, smoking
habits (active or previous), alcoholism and obesity were
registered prospectively in our local neurosonology database.
Statistical analysis
We conducted a cross sectional study of associations of
clinical, demographic and neurosonologic variables with
different locations of SHPVO.
Statistical analyses were performed using the SPSS
17.0 software package. Descriptive statistics of the wholepopulation included mean (standard deviation) for con-
tinuous variables and number (percentage) for categorical
variables.
Considering the large number of patients studied we
conducted a multivariate analysis including all clinical,
demographic and ultrasonographic characteristics to de-
termine independent associations with SHPVO using a
multivariate ordinal logistic regression model. This model
was performed identically for predictors of DWMH,
PVWMH and BGH. We also conducted a multivariate or-
dinal logistic regression model including all demographic
and clinical variables but excluding the neurosonologic
variables for predictors of DWMH, PVWMH and BGH.
Statistical significance for inclusion was set at p < 0.05.
Results
During the study period 1015 patients were submitted to
ultrasonographic evaluation in our cerebral hemodynamic
laboratory. We excluded 576 (56.7%) patients due to ex-
clusion criteria, thus including 439 patients (Figure 1).
The descriptive analysis of clinical, demographic and neu-
rosonologic characteristics are expressed in Table 1.
In multivariate analysis including all clinical, demo-
graphic and neurosonologic variables age, hypertension
and mean PI were the only independent predictors of
DWMH, PVWMH and BGH (Table 2).
In a multivariate ordinal logistic regression model in-
cluding all clinical and demographic variables, but exclu-
ding mean PI and IMT, the independent predictors of
SHPVO were age and hypertension for all locations. Re-
garding DWMH: OR = 1.087, 95%CI = 1.069-1106, p <
0.001 for age and OR = 2.023, 95%CI: 1.305-3.134,
Table 1 Clinical demographic and neurosonologic
characteristics of the whole study population
Variable Total population
Age 63.47 (14.94)
Male gender 294 (67.0%)
Hypertension 292 (66.5%)




Heart failure 21 (4.8%)
Obesity 39 (8.9%)




Continuous variables are presented as mean (standard deviation), categorical
variables as number (percentage). (PI = Pulsatility Index; IMT = Intima
Media Thickness).
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1.086, 95%CI: 1.068-1.104, p < 0.001 and hypertension:
OR = 2.038, 95%CI = 1.329-3.125, p = 0.001. The predic-
tors of BGH were age (OR = 1.072, 95%CI = 1.053-1.091,
p < 0.001) and hypertension (OR = 1.912, 95%CI = 1.205-
3.034, p = 0.006).
Discussion
The main finding of our work is that different topo-
graphic involvement of white matter changes is in-
dependently associated with the same clinical and
neurosonological features.Table 2 Results of the multivariate ordinal logistic regression
Variable Deep white matter hypodensities Perivent
OR 95% CI p OR
Age 1.067 1.047-1.088 <0.001 1.068
Male gender 0.874 0.569-1.345 0.541 0.714
Hypertension 1.909 1.222-2.981 0.004 1.907
Diabetes mellitus 1.158 0.741-1.81 0.52 1.283
Smoking 1.039 0.546-1.975 0.908 0.816
Dyslipidemia 1.149 0.779-1.697 0.186 1.179
Coronariopathy 0.483 0.165-1.411 0.183 0.842
Heart Failure 1.203 0.485-2.979 0.69 1.63
Obesity 1.958 0.991-3.871 0.053 1.074
Peripheral artery disease 2.346 0.345-15.961 0.384 1.783
Alcoholism 1.709 0.715-4.087 0.228 0.81
PI 17.994 6.875-47.1 <0.001 5.739
IMT 0.949 0.285-3.163 0.932 1.795
PI = Pulsatility Index; IMT = Intima Media Thickness; OR = Odds Ratio; 95% CI = 95%Small vessel disease has recently received increasing
awareness to its pathogenesis. In fact, despite being recog-
nized as one of the major worldwide causes of cognitive,
physical and psychiatric impairment, the underlying
mechanisms have largely maintained undetermined with
paralleled treatment limitations. As such, a multinational
consensus group recently published neuroimaging stan-
dards and identified the major knowledge gaps in the field.
Subcortical hyperintensities of presumed vascular origin
are one of the hallmark imaging presentations of SVD.
Recognized to involve the deep and periventricular white
matter as well as subcortical grey matter and brainstem,
their etiopathogenesis has remained speculative and is in-
dicated as one of the main controversies. In this study we
tried to answer some questions still open: Are subcortical
hypodensities in different locations associated with differ-
ent risk factors? What is their relation with extracranial
atherosclerosis and cerebrovascular resistance?
In our study the brain parenchyma was evaluated with
CT. Although not ideal, CT evaluation of white matter
changes is acceptable, particularly in the setting of large-
scale studies [8]. Differences of MRI and CT in detecting
SHPVO are primarily related to lesion size, being MRI
more sensitive in detecting small SHPVO. Nonetheless,
CT is as good as MRI in detecting larger, clinically rele-
vant lesions [2] and a recent systematic review showed
there is no difference between these imaging methods in
diagnostic accuracy of a vascular component to demen-
tia [25]. The ARWMC rating scale by the European Task
Force on Age-Related White Matter Changes was devel-
oped with the intent to be applied in clinical trials using
either CT or MRI studies, and has shown a good reli-
ability for both imaging techniques [2]. Notably, the
ARWMC scale does not include a specific grading forwith independent predictors of SHPVO
ricular white matter hypodensities Basal Ganglia hypodensities
95% CI p OR 95% CI p
1.049-1.088 <0.001 1.05 1.03-1.071 <0.001
0.471-1.082 0.112 1.298 0.825-2.042 0.26
1.238-2.938 0.003 1.775 1.109-2.843 0.017
0.826-1.992 0.268 1.2 0.764-1.885 0.429
0.434-1.533 0.527 0.895 0.456-1.758 0.748
0.807-1.723 0.393 1.01 0.675-1.511 0.963
0.298-2.38 0.745 0.877 0.308-2.497 0.805
0.68-3.911 0.273 1.301 0.517-3.273 0.576
0.549-2.102 0.835 1.169 0.571-2.392 0.669
0.267-11.909 0.551 1.366 0.195-9.584 0.754
0.339-1.936 0.636 2.173 0.911-5.185 0.08
2.288-14.397 <0.001 11.844 4.486-31.268 <0.001
0.549-5.874 0.333 1.3 0.379-4.461 0.677
confidence interval.
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this subset of SHPVO we used the operacionalized
ARWMC scale [24], which has shown good inter-rater
reliability and is also applicable to CT [24]. A natural
limitation of CT is in the study of infratentorial lesions.
As such, we chose not to evaluate subcortical changes in
the brainstem. In the aforementioned consensus paper
the proposed terminology for these imaging findings
when involving white matter as well as subcortical grey
matter and brainstem is subcortical hyperintensities of
presumed vascular origin. In our study, considering we
used CT as the primary imaging method, we chose to
use the concept of subcortical hypodensities of pre-
sumed vascular origin (SHPVO). The choice of using
CT in this study was due primarily to the possibility of
including a large sample population with accurate docu-
mentation of vascular risk factors and neurosonological
characterization. Moreover, the chronological proximity
of both neuroimaging and neurosonology further in-
creases the reliability of the results.
The clinical and demographic characteristics of our pa-
tients are in line with what is to be expected considering
our study population and previous reports on SHPVO [4,5].
Our results show an independent association of SHPVO
with older age and arterial hypertension, irrespective of
the remaining risk factors. These associations remained
significant even after inclusion of neurosonological vari-
ables in the regression model. The comprehension of the
relationship between vascular risk factors and SVD is only
at its infancy. Recent evidence supports the hypothesis
that early endothelial failure, with disruption of the vessel
wall architecture and leakage of plasma is a main precipi-
tant of sporadic SVD [1]. The subsequent production of
perivascular edema, which is toxic, induces rarefaction
and demyelination which is seen pathologically as white
matter hyperintensities on MRI or hypodensities in CT
[1]. Age has invariably been associated SHPVO [5,26],
with reported prevalences of up to 92% in the elderlyFigure 2 Distribution of mean pulsatility indexes in middle cerebral a
location (deep white matter, periventricular and basal ganglia hypod
confidence intervals.[4,27,28]. The explanation of this common finding, might
rely on the fact that cerebrovascular endothelium becomes
increasingly permeable with age and some evidence sug-
gests that age has an exponential correlation with the loss
of blood-barrier function [29]. Hypertension is a key risk
factor for white matter pathology but the mechanism of
this association is complex and many explanations have
been proposed. An highly heritable component [30,31]
has been documented, and together with the fact that
some patients with sustained normal blood pressure still
develop SHPVO raises the hypothesis that this relation
may be at the genetic locus rather than directly causal [1].
The hypothesis of early endothelial damage with blood-
barrier dysfunction, favors an immune-mediated myelin
damage rather than an atherosclerotic phenomenon in
the etiology of SVD. This theory is reinforced by the in-
consistent association of traditional vascular risk factors
(other than age and hypertension) with SHPVO
[27,32,33]. Our findings support this data particularly by
the absent association with IMT. The quantification of
the intima-media layer in the carotid artery [34] is one
of the most commonly used surrogate markers of ath-
erosclerosis and has been shown to predict future clin-
ical atherosclerotic complications both cerebrovascular
and coronary [18,35]. Our study did not show an inde-
pendent association of IMT with SHPVO, once again
corroborating a lack of causality of extracranial athero-
sclerosis with SHPVO.
Different topographic involvement of SHPVO seems
to be associated with the same clinical and neurosono-
logical features. A possible explanation for a differential
topographic involvement of the same pathological condi-
tion comes from histological data reporting looser endo-
thelial junctions in arteriolar and venular endothelium
rather than capillaries [1,36]. Consequently, early endothe-
lial dysfunction would firstly be translated in an affection
of proximal perforating arterioles with lacunar infarcts in
the basal ganglia, following subcortical white matterrteries (MCA) according to the grade of SHPVO (0–3) for each
ensities). Values are represented in error bars with mean and 95%
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vale and periventricular area. This would favour the hy-
pothesis of a pathological continuum from the same
process with heterogeneous extension according to the
primary site of physiological impairment.
Pulsatility Index of MCAs is a measure of intracranial
pulsatility and is dependent on cerebrovascular resistance
but also cardiac output and arterial wall pathologies with
pre or post-stenotic/occlusive hemodynamic effects. As
such, patient with hemodynamic confounders, as well as
other pathologies capable of altering cerebral pulsatility
(like subarachnoid hemorrhage, acute ischemic stroke,
intracranial hypertension, brain death or arteriovenous
malformations) were excluded. Patients with atrial fibrilla-
tion were also excluded due to the impossibility of cor-
rectly assessing pulsatility in an irregular pulse pattern.
Furthermore, the control for cardiac failure and rest pos-
ition during evaluation guaranteed that the PI observed in
the MCAs was due exclusively to intracranial cerebrovas-
cular resistance. Cerebral hemodynamics has shown an in-
consistent association with SHPVO [37-40] or in aiding
differentiation between types of dementia [38,39]. Our
study adds evidence to this association (Figure 2) re-
inforcing the role of thickened arteriolar walls and thus
cerebrovascular resistance in the pathogenic cascade of
SHPVO, emerging as a probable consequence of endothe-
lial dysfunction in arterioles. This can account for the posi-
tive association of PI and SHPVO, considering the early
predisposition of arterioles to endothelial damage due to
looser endothelial tight junctions, with leakage of plasma,
perivascular edema, and at this location, disruption of the
normal architecture including damaged arteriolar smooth
muscle (absent in capillaries) and fibrin deposition,
impairing their autoregulatory capacity. The previous
discrepancies between studies are possibly explained by
absent control for some situations causing altered cere-
bral hemodynamics and selection bias. Therefore in
this study we chose to analyse consecutive patients.
These are results from a single-centred analysis, nonethe-
less a significant number of patients was analysed and data
with clinical importance were drawn from its analysis.
Moreover, blood pressure was not assessed at the time of
the neurosonologic exam, which can affect arterial pulsati-
lity. However, the effect of intracranial pulsatility was
determined after adjustment for hypertension, indica-
ting an independent association. Considering the safety
and easy accessibility of transcranial ultrasound, these
findings present cerebral PI as a biomarker in primary
and secondary prevention of SHPVO.
The inclusion of patients with neuroimaging performed
by CT alone is an obvious bias. Nonetheless, the use of
validated neuroimaging scores and considering the graded
analysis of SHPVO other than an absolute quantification
of lesions allows an accurate interpretation of the data.Furthermore, this technique enabled the inclusion of a
large number of sequential, unselected subjects, increasing
the validity of the conclusions.
Multi-centre prospective trials to assess drugs poten-
tially capable of modulating cerebral hemodynamics are
mandatory and may help to finally determine the role of
PI as biomarker of SHPVO. Moreover, when analysing
intracranial pulsatility, confounders for hemodynamic ef-
fects should be carefully taken under consideration to
minimize discrepant results.
Conclusions
Our results indicate that age, hypertension and intracra-
nial pulsatility are the main independent predictors of
SHPVO across different topographic involvement and
irrespective of atherosclerotic involvement, suggesting
a possible common etiological mechanism.
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